BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19853327)

  • 1. Synthesis of some new pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer and radioprotective activity.
    Ghorab MM; Ragab FA; Alqasoumi SI; Alafeefy AM; Aboulmagd SA
    Eur J Med Chem; 2010 Jan; 45(1):171-8. PubMed ID: 19853327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling study and synthesis of novel pyrrolo[2,3-d]pyrimidines and pyrrolotriazolopyrimidines of expected antitumor and radioprotective activities.
    Abou El Ella DA; Ghorab MM; Noaman E; Heiba HI; Khalil AI
    Bioorg Med Chem; 2008 Mar; 16(5):2391-402. PubMed ID: 18086527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, anticancer and radioprotective activities of some new pyrazolo[3,4-d]pyrimidines containing amino acid moieties.
    Ghorab MM; Ragab FA; Noaman E; Heiba HI; Aboulmagd SA
    Arzneimittelforschung; 2009; 59(2):96-103. PubMed ID: 19338140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of certain new thiieno [2,3-d] pyrimidines as potential antitumor and radioprotective agents.
    Ghorab MM; Ragab FA; Noaman E; Heiba HI; Galal M
    Arzneimittelforschung; 2006; 56(7):553-60. PubMed ID: 16927539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of some novel sulfur containing triazolothienopyrimidines and biscompounds as possible antitumor and radioprotective agents.
    Heiba HI; Ragab FA; Noaman E; Ghorab MM; Galal M
    Arzneimittelforschung; 2006; 56(8):593-9. PubMed ID: 17009841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives.
    El-Said MS; El-Gazzar MG; Al-Dosari MS; Ghorab MM
    Arzneimittelforschung; 2012 Mar; 62(3):149-56. PubMed ID: 22270843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel thiophenes, thienopyrimidines, and triazolothienopyrimidines for the evaluation of anticancer and augmentation effects of gamma-radiation.
    Shaaban MA; Ghorab MM; Heiba HI; Kamel MM; Zaher NH; Mostafa MI
    Arch Pharm (Weinheim); 2010 Jul; 343(7):404-10. PubMed ID: 20379969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antitumor and radioprotective sulfonamides containing pyrrolo [2,3-d]pyrimidines.
    Ghorab MM; Noaman E; Ismail MM; Heiba HI; Ammar YA; Sayed MY
    Arzneimittelforschung; 2006; 56(6):405-13. PubMed ID: 16889123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines.
    Li J; Zhao YF; Zhao XL; Yuan XY; Gong P
    Arch Pharm (Weinheim); 2006 Nov; 339(11):593-7. PubMed ID: 17036367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anticancer effects of some novel pyrazolo[3,4-d]pyrimidine derivatives by generating reactive oxygen species in human breast adenocarcinoma cells.
    Rashad AE; Mahmoud AE; Ali MM
    Eur J Med Chem; 2011 Apr; 46(4):1019-26. PubMed ID: 21315495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
    Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
    El-Sayed Ali T
    Eur J Med Chem; 2009 Nov; 44(11):4385-92. PubMed ID: 19586688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
    Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
    Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancerostatica. I. synthesis of some pyrazolo[1,5-a]pyrimidine and pyrazolo [3,4-b] pyridine derivatives.
    Nantka-Namirski P; Kaczmarek L
    Pol J Pharmacol Pharm; 1978; 30(4):563-8. PubMed ID: 740557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral and cytostatic evaluations of the new C-5 substituted pyrimidine and furo[2,3-d]pyrimidine 4',5'-didehydro-L-ascorbic acid derivatives.
    Gazivoda T; Sokcević M; Kralj M; Suman L; Pavelić K; De Clercq E; Andrei G; Snoeck R; Balzarini J; Mintas M; Raić-Malić S
    J Med Chem; 2007 Aug; 50(17):4105-12. PubMed ID: 17672445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety.
    Abdel-Aziz HA; Saleh TS; El-Zahabi HS
    Arch Pharm (Weinheim); 2010 Jan; 343(1):24-30. PubMed ID: 19921685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel pyrazoles and pyrazolo[3,4-d]pyrimidines incorporating a benzenesulfonamide moiety.
    Ashour HM; Wahab AE
    Arch Pharm (Weinheim); 2009 Apr; 342(4):238-52. PubMed ID: 19340837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
    Witkiewicz K; Machoń Z; Mordarski M; Wieczorek J
    Pol J Pharmacol Pharm; 1987; 39(6):715-20. PubMed ID: 3503990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives as potential anti-breast cancer agents.
    Abd El Hamid MK; Mihovilovic MD; El-Nassan HB
    Eur J Med Chem; 2012 Nov; 57():323-8. PubMed ID: 23085106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.